ViaDerma (VDRM) News Today 0.0078 0.00 (-10.34%) (As of 11/22/2024 08:54 PM ET) Add Compare Share Share Headlines Stock AnalysisChartShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period ViaDerma, Inc. Reports Strong Financial Results for Q2 2024, Achieving Positive Net Income and Significant Cash Flow GrowthOctober 3, 2024 | finance.yahoo.comViaDerma Completes First Shipment of 500,000 Units to NigeriaSeptember 10, 2024 | stockhouse.comViaDerma Announces Shipment of 500,000 Units of its Flagship Product to NigeriaAugust 14, 2024 | finance.yahoo.comViaDerma Announces Shipment of 500,000 Units of its Flagship Product to NigeriaAugust 13, 2024 | globenewswire.comViaDerma Finalizes Distribution Agreements in Dubai and Announces Six New Key HiresAugust 1, 2024 | globenewswire.comViaDerma Provides Highlights of Quarterly Financial ReportJune 6, 2024 | globenewswire.comViaDerma, Inc. (VDRM)May 16, 2024 | finance.yahoo.comViaDerma Inc VDRMMarch 3, 2024 | morningstar.comViaDerma Update on Stability Testing, Global Sales Distribution, National Licensing, Nupelo & MoreOctober 24, 2023 | finance.yahoo.comViaDerma Announces Updates for Vitastem Global Sales Expansion, Nupelo FDA-Registration Status & MoreJuly 6, 2023 | finance.yahoo.comViaDerma, Inc. (VDRM) Stock Historical Prices & Data - Yahoo FinanceApril 18, 2023 | finance.yahoo.comViaDerma Announces FDA Registration Application Update & Brand Name for New Hair Regrowth ProductMarch 16, 2023 | finance.yahoo.comViaDerma Announces Intent to Launch a New Minoxidil Hair Regrowth ProductMarch 8, 2023 | finance.yahoo.comViaDerma Provides an Update on Current & Future Business ActivitiesMarch 2, 2023 | finance.yahoo.comViaDerma Retains Digital Marketing Leader INTENT SCIENCES to Accelerate Business Growth OnlineJanuary 12, 2023 | benzinga.comViaDerma Successfully Completes Quality Control Testing of its New Vitastem ProductsSeptember 15, 2022 | finance.yahoo.comViaDerma Announces the Implementation of Internal Quality Control Measures for its New Vitastem ProductsJune 22, 2022 | finance.yahoo.comAvoteo emerges as the first crowdfunding platform without spending moneyApril 1, 2022 | nz.finance.yahoo.comVictoria and David Beckham's UK home 'burgled' while daughter Harper was asleep upstairsApril 1, 2022 | yahoo.comOur existence isn't new, but now transgender people are visible like never beforeApril 1, 2022 | yahoo.comViaDerma's 2021 Annual Report Shows Strong Revenue Growth Over the Previous YearMarch 31, 2022 | finance.yahoo.comViaDerma, Inc. Set to Launch Two New and Improved Versions of its Flagship Product, Vitastem and Vitastem UltraOctober 4, 2021 | finance.yahoo.comViaDerma, Inc. Files Amended Financial StatementsAugust 24, 2021 | finance.yahoo.comViaDerma Inc.August 21, 2021 | barrons.com Get ViaDerma News Delivered to You Automatically Sign up to receive the latest news and ratings for VDRM and its competitors with MarketBeat's FREE daily newsletter. Email Address Donald Trump can’t save you from this crisis (Ad)Elon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force will put millions of Americans out of work. The ripple effects could nudge the US economy into a catastrophic tailspin. If this happens, you need to be prepared. That’s why a former Trump advisor is sharing his contingency plan with the public. What is Musk talking about? Get the full details now. VDRM Media Mentions By Week VDRM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VDRM News Sentiment▼0.000.49▲Average Medical News Sentiment VDRM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VDRM Articles This Week▼00▲VDRM Articles Average Week Get ViaDerma News Delivered to You Automatically Sign up to receive the latest news and ratings for VDRM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies 4Front Ventures News Algernon Pharmaceuticals News Allstar Health Brands News Alvotech News American Premium Mining News Anew Medical News Arno Therapeutics News AstraZeneca News AVVAA World Health Care Products News Basilea Pharmaceutica News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:VDRM) was last updated on 11/24/2024 by MarketBeat.com Staff From Our PartnersNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredShocking footage from Bill Gates’ $100,000,000,000 AI BetIf you missed out on Nvidia, watch this video I just made.Brownstone Research | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredThe #1 ETF for monthly incomeWe just found the #1 ETF for monthly income. This outlier is paying a huge 22% dividend... And you could...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ViaDerma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ViaDerma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VDRM Stock Alerts